Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer

BACKGROUND: Molecular biomarker tests are developed as diagnostic tools for prostate cancer (PCa) diagnosis. The SelectMDx (MDxHealth, Nijmegen, The Netherlands) test is a urinary-based biomarker test intended to be used to predict presence of high-grade PCa upon biopsy in men with elevated serum pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Visser, Wieke C. H., de Jong, Hans, Steyaert, Sandra, Melchers, Willem J. G., Mulders, Peter F. A., Schalken, Jack A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385481/
https://www.ncbi.nlm.nih.gov/pubmed/35810263
http://dx.doi.org/10.1038/s41391-022-00562-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385481/
https://www.ncbi.nlm.nih.gov/pubmed/35810263
http://dx.doi.org/10.1038/s41391-022-00562-1

Ejemplares similares